ATE478655T1 - Pharmazeutische zusammensetzung zur oralen verabreichung - Google Patents

Pharmazeutische zusammensetzung zur oralen verabreichung

Info

Publication number
ATE478655T1
ATE478655T1 AT07721847T AT07721847T ATE478655T1 AT E478655 T1 ATE478655 T1 AT E478655T1 AT 07721847 T AT07721847 T AT 07721847T AT 07721847 T AT07721847 T AT 07721847T AT E478655 T1 ATE478655 T1 AT E478655T1
Authority
AT
Austria
Prior art keywords
independently
carbon atoms
group
another
pharmaceutically acceptable
Prior art date
Application number
AT07721847T
Other languages
English (en)
Inventor
Ales Franc
Petr Sova
Original Assignee
Pliva Lachema As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Lachema As filed Critical Pliva Lachema As
Application granted granted Critical
Publication of ATE478655T1 publication Critical patent/ATE478655T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT07721847T 2006-06-20 2007-06-20 Pharmazeutische zusammensetzung zur oralen verabreichung ATE478655T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20060402A CZ300424B6 (cs) 2006-06-20 2006-06-20 Farmaceutická kompozice pro perorální podání
PCT/CZ2007/000058 WO2007147371A2 (en) 2006-06-20 2007-06-20 Pharmaceutical composition for oral administration

Publications (1)

Publication Number Publication Date
ATE478655T1 true ATE478655T1 (de) 2010-09-15

Family

ID=38819283

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07721847T ATE478655T1 (de) 2006-06-20 2007-06-20 Pharmazeutische zusammensetzung zur oralen verabreichung

Country Status (18)

Country Link
US (1) US7767709B2 (de)
EP (1) EP2034957B1 (de)
JP (1) JP2009541227A (de)
KR (1) KR20090048436A (de)
CN (1) CN101505727A (de)
AT (1) ATE478655T1 (de)
AU (1) AU2007262493A1 (de)
CZ (1) CZ300424B6 (de)
DE (1) DE602007008724D1 (de)
DK (1) DK2034957T3 (de)
ES (1) ES2358205T3 (de)
IL (1) IL196100A0 (de)
PL (1) PL2034957T3 (de)
PT (1) PT2034957E (de)
RU (1) RU2430718C2 (de)
SI (1) SI2034957T1 (de)
UA (1) UA93404C2 (de)
WO (1) WO2007147371A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ296459B6 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
BR112014029131B1 (pt) * 2012-05-31 2021-03-09 Allergan Pharmaceuticals International Limited cápsula de mucoadesivo
EP3386997B1 (de) 2015-12-09 2021-06-30 Medizinische Universität Wien Monomaleimid-funktionalisierte platinverbindungen zur krebstherapie

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328218D0 (en) * 1983-10-21 1983-11-23 Johnson Matthey Plc Oral compositions
DE68918878T2 (de) * 1988-02-02 1995-02-23 Johnson Matthey Inc Pt(IV) Komplexe.
JPH02290813A (ja) * 1989-04-28 1990-11-30 Sumitomo Pharmaceut Co Ltd ヨード化油および脂溶性白金（２）錯体からなる制癌組成物
FI905018A0 (fi) * 1989-10-17 1990-10-12 Bristol Myers Squibb Co I vatten och loesningsmedel loesliga axiala hydroxi-och mono- och dikarboxylsyraderivat med stor tumoeraktivitet.
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
WO1996026949A1 (fr) * 1995-02-28 1996-09-06 Debiopharm Sa Nouveaux complexes de platine (iv), leur procede de production et agents cancerostatiques les contenant
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
ES2234094T3 (es) * 1997-02-05 2005-06-16 PHARMACIA & UPJOHN COMPANY LLC Complejos de lipidos a base de complejos de platino altamente insolubles.
JPH10265380A (ja) * 1997-03-17 1998-10-06 Bristol Myers Squibb Co 抗ガン剤
KR100246722B1 (ko) * 1997-12-30 2000-04-01 박호군 경구용 백금 착화합물 항암제 및 그 제조방법
CZ288912B6 (cs) * 1998-05-27 2001-09-12 Lachema, A. S. Komplex platiny v oxidačním čísle IV, způsob přípravy tohoto komplexu, tento komplex jako léčivo a farmaceutická kompozice tento komplex obsahující
PE20001227A1 (es) * 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
AU2001277711A1 (en) * 2000-08-11 2002-02-25 Sumitomo Pharmaceuticals Co. Ltd. Remedies for cisplatin-tolerant cancer
US20030082102A1 (en) * 2001-06-25 2003-05-01 Court Wayne S. Radioactive platinum complexes for cancer treatment
EP1424889A4 (de) * 2001-08-20 2008-04-02 Transave Inc Verfahren zur behandlung von lungenkarzinomen
AU2003293140A1 (en) * 2002-11-26 2004-06-18 Gilead Sciences, Inc. Method of drug loading in liposomes by gradient
CZ295584B6 (cs) * 2004-02-12 2005-08-17 Pliva-Lachema A. S. Farmaceutická kompozice obsahující jako účinnou látku platinový komplex a způsob výroby této kompozice
CZ296045B6 (cs) * 2003-03-31 2005-12-14 Pliva-Lachema A. S. Farmaceutická kompozice obsahující jako účinnou látku komplex čtyřmocné platiny a způsob její výroby
MX2007004955A (es) * 2004-11-08 2007-06-14 Transave Inc Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
ES2327421T3 (es) * 2005-03-11 2009-10-29 Gpc Biotech Ag Terapia antiproliferativa combinada que comprende satraplatino o jm118 y docetaxel.
EP1792622A1 (de) * 2005-11-11 2007-06-06 GPC Biotech AG Antiproliferative Kombinationstherapie mit einem Platin enthaltenden chemotherapeutischen Mittel und EGFR-Inhibitoren oder Pyrimidinanaloga
CZ300590B6 (cs) * 2006-06-20 2009-06-24 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
CZ300120B6 (cs) * 2006-06-20 2009-02-11 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání

Also Published As

Publication number Publication date
CN101505727A (zh) 2009-08-12
PT2034957E (pt) 2010-11-30
US20100010083A1 (en) 2010-01-14
WO2007147371A2 (en) 2007-12-27
WO2007147371B1 (en) 2008-06-19
UA93404C2 (ru) 2011-02-10
JP2009541227A (ja) 2009-11-26
RU2430718C2 (ru) 2011-10-10
KR20090048436A (ko) 2009-05-13
DE602007008724D1 (de) 2010-10-07
PL2034957T3 (pl) 2011-04-29
US7767709B2 (en) 2010-08-03
CZ300424B6 (cs) 2009-05-13
EP2034957A2 (de) 2009-03-18
DK2034957T3 (da) 2010-12-20
IL196100A0 (en) 2009-09-01
RU2009101498A (ru) 2010-07-27
WO2007147371A3 (en) 2008-04-17
ES2358205T3 (es) 2011-05-06
EP2034957B1 (de) 2010-08-25
SI2034957T1 (sl) 2011-03-31
CZ2006402A3 (cs) 2007-12-27
AU2007262493A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
TW200626158A (en) Naphthaline derivatives
DE602006006712D1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
SI3002283T1 (en) Thiazole derivatives
ATE517882T1 (de) Chinolinderivate
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
TW200637817A (en) 5-aminoindole derivatives
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
MA29653B1 (fr) Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA31567B1 (fr) Derives de 7 -alkynyl-1.8-naphthyrid0nes, leur preparation et leur application en therapeutique
BRPI0407968A (pt) derivados de oxamida úteis como inibidores de raf-quinase
ATE478655T1 (de) Pharmazeutische zusammensetzung zur oralen verabreichung
MX2009005242A (es) Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo.
ATE488243T1 (de) Pharmazeutische zusammensetzung zur injektion, insbesondere zur gezielten lokalen anwendung
ATE448223T1 (de) 8-azabicycloä3.2.1üoctanderivate und ihre verwendung als monoamine-neurotransmitter- reuptake inhibitoren
UA93715C2 (ru) Фармацевтическая композиция для инъекционного введения ha ochobe соединения четырехвалентной платины и циклодекстрина
PL1732902T3 (pl) Pochodne nukleozydów i ich terapeutyczne zastosowanie
TN2012000267A1 (fr) Nouveaux derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA29648B1 (fr) Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UA93878C2 (ru) Производная бензилпиперазина, ee применение при лечении разных расстройств и фармацевтическая композиция, которая ee содержит
TN2010000542A1 (fr) Nouveaux derives azabicylco[3.2.0]hept 3-yl leur procede de preparation et les compositons pharmaceutiques qui les contiennent
BRPI0507269A (pt) compostos, tautÈmeros, estereoisÈmeros, pró-drogas e sais dos mesmos, composições farmacêuticas,e , uso de um composto
CU23368A3 (es) Piridonas sustituidas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties